Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |